HEM Pharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Apr '26 Apr 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	449,667	327,494	114,874
Market Cap Growth	207.56%	185.09%	-
Enterprise Value	455,366	334,986	-
Last Close Price	62700.00	45850.00	16500.00
PS Ratio	34.64	25.23	7.62
PB Ratio	86.23	62.80	4.40
P/TBV Ratio	127.43	92.81	4.54
EV/Sales Ratio	35.08	25.81	-
Debt / Equity Ratio	3.69	3.69	0.30
Net Debt / Equity Ratio	1.05	1.05	-0.13
Net Debt / EBITDA Ratio	-0.42	-0.42	0.66
Net Debt / FCF Ratio	-0.30	-0.30	0.28
Asset Turnover	0.29	0.29	-
Inventory Turnover	9.97	9.97	-
Quick Ratio	0.38	0.38	1.73
Current Ratio	0.56	0.56	1.91
Return on Equity (ROE)	-151.43%	-151.43%	-
Return on Assets (ROA)	-21.96%	-21.96%	-
Return on Capital Employed (ROCE)	-137.30%	-137.30%	-27.60%
Earnings Yield	-5.30%	-7.28%	-6.66%
FCF Yield	-4.03%	-5.53%	-10.77%
Buyback Yield / Dilution	-10.69%	-10.69%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.